US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method
Patent 7326705 was granted and assigned to Bristol-Myers Squibb on February, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
David S. Weinstein0
Karnail S. Atwal0
Khehyong Ngu0
Saleem Ahmad0
Shung C. Wu0
Steven V. O'Neil0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+115 characters)
Article
Patent abstract
Heterocyclic are provided which are sodium/proton exchange (NHE) inhibitors which have the structure
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07326705 Heterocyclic sodium/proton exchange inhibitors and method US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method
Infobox
Patent Number
073267050
Patent Number
73267050
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073267050
Date of Patent
February 5, 2008
0Patent Application Number
110469930
Date Filed
January 31, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07326705 Heterocyclic sodium/proton exchange inhibitors and method
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07326705
Date of patent
February 5, 2008
Patent application number
11046993
Date Filed
January 31, 2005
Patent primary examiner
Find more entities like US Patent 7326705 Heterocyclic sodium/proton exchange inhibitors and method
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
